Does NIVOLUMAB Cause Hyperkeratosis? 76 Reports in FDA Database

Q: Does NIVOLUMAB cause Hyperkeratosis?

76 reports of Hyperkeratosis have been filed with the FDA for NIVOLUMAB, representing 0.1% of all NIVOLUMAB adverse event reports.

Q: How dangerous is Hyperkeratosis from NIVOLUMAB?

Of 76 reports, 2 (2.6%) resulted in death and 13 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 76 reports of Hyperkeratosis have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.1% of all adverse event reports for NIVOLUMAB.

Reports of Hyperkeratosis with NIVOLUMAB

0.1%

of all NIVOLUMAB reports

Deaths

Hospitalizations

How Dangerous Is Hyperkeratosis From NIVOLUMAB?

Of the 76 reports, 2 (2.6%) resulted in death, 13 (17.1%) required hospitalization.

Is Hyperkeratosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 76 reports have been filed with the FAERS database.

What Other Side Effects Does NIVOLUMAB Cause?

Death (11,216) Malignant neoplasm progression (9,363) Off label use (5,208) Diarrhoea (4,692) Fatigue (3,709) Pyrexia (3,454) Intentional product use issue (3,297) Rash (2,816) Nausea (2,805) Decreased appetite (2,619)

What Other Drugs Cause Hyperkeratosis?

CABOZANTINIB S-MALATE (411) ADALIMUMAB (332) SUNITINIB MALATE (170) ETANERCEPT (168) SORAFENIB (150) METHOTREXATE (149) VEMURAFENIB (145) REGORAFENIB (136) RIPRETINIB (124) RITUXIMAB (121)

Which NIVOLUMAB Alternatives Have Lower Hyperkeratosis Risk?

NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW NIVOLUMAB vs NIZATIDINE NIVOLUMAB vs NOMEGESTROL NIVOLUMAB vs NORDAZEPAM NIVOLUMAB vs NOREPINEPHRINE

NIVOLUMAB Full Profile All Hyperkeratosis Reports All Drugs Causing Hyperkeratosis NIVOLUMAB Demographics